These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New insights into the role of adipose tissue in thrombosis. Vilahur G; Ben-Aicha S; Badimon L Cardiovasc Res; 2017 Jul; 113(9):1046-1054. PubMed ID: 28472252 [TBL] [Abstract][Full Text] [Related]
4. Role of fibrinolysis in obesity and thrombosis. Lijnen HR Thromb Res; 2009; 123 Suppl 4():S46-9. PubMed ID: 19303504 [TBL] [Abstract][Full Text] [Related]
5. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1. Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230 [TBL] [Abstract][Full Text] [Related]
6. Thrombosis in the setting of obesity or inflammatory bowel disease. Lentz SR Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):180-187. PubMed ID: 27913478 [TBL] [Abstract][Full Text] [Related]
8. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. McFadyen JD; Stevens H; Peter K Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214 [TBL] [Abstract][Full Text] [Related]
11. Thrombosis in the setting of obesity or inflammatory bowel disease. Lentz SR Blood; 2016 Nov; 128(20):2388-2394. PubMed ID: 27856470 [TBL] [Abstract][Full Text] [Related]
12. Links between adipose tissue and thrombosis in the mouse. Bodary PF Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2284-91. PubMed ID: 17761944 [TBL] [Abstract][Full Text] [Related]
13. Risk and management of thrombosis in multiple myeloma. Leebeek FW; Kruip MJ; Sonneveld P Thromb Res; 2012 Apr; 129 Suppl 1():S88-92. PubMed ID: 22682142 [TBL] [Abstract][Full Text] [Related]
14. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation. Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049 [TBL] [Abstract][Full Text] [Related]
15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolysis abnormalities in obesity. De Pergola G; Pannacciulli N J Endocrinol Invest; 2002 Nov; 25(10):899-904. PubMed ID: 12508953 [TBL] [Abstract][Full Text] [Related]
17. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
18. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Fuster JJ; Ouchi N; Gokce N; Walsh K Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642 [TBL] [Abstract][Full Text] [Related]
19. Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis. Lisman T Semin Thromb Hemost; 2017 Mar; 43(2):178-184. PubMed ID: 27472427 [TBL] [Abstract][Full Text] [Related]
20. Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction. Piestrzeniewicz K; Łuczak K; Komorowski J; Jankiewicz-Wika J; Goch JH Neuro Endocrinol Lett; 2007 Aug; 28(4):427-32. PubMed ID: 17693973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]